Trial Profile
Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2022
Price :
$35
*
At a glance
- Drugs Birch triterpenes (Primary)
- Indications Burns
- Focus Registrational; Therapeutic Use
- Sponsors Birken AG
- 01 Apr 2015 According to the the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 12 Jun 2014 New trial record